Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is pretreatment PSA velocity associated with prostate-cancer-specific mortality rate after radiotherapy?

Nature Clinical Practice Urology volume 3, pages 12–13 (2006)Cite this article

boxed-textD'Amico AV et al. (2005) Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA 294: 440–447

Although not every man with a pretreatment PSA velocity of >2 ng/ml/year will die of prostate cancer progression, these patients have a poor prognosis and should be treated aggressively

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Roach M 3rd et al. (2003) Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate. Urology 61: 730–735

    Article  Google Scholar 

  2. D'Amico AV et al. (2004) Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351: 125–135

    Article  CAS  Google Scholar 

  3. Coen JJ et al. (2002) Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. J Clin Oncol 20: 3199–3205

    Article  Google Scholar 

  4. Hanks GE et al. (2003) Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 21: 3972–3978

    Article  CAS  Google Scholar 

  5. Jacob R et al. (2004) The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer. Cancer 100: 538–543

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Chairman and the Gerald E Hanks MD Endowed Chair of the Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

    Alan Pollack

Authors
  1. Alan Pollack
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan Pollack.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pollack, A. Is pretreatment PSA velocity associated with prostate-cancer-specific mortality rate after radiotherapy?. Nat Rev Urol 3, 12–13 (2006). https://doi.org/10.1038/ncpuro0399

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0399

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing